Company / Cash per Share
Gilead Sciences Cash per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.26
FY2021
5-year range
$4.26 / $4.26
FY2017-FY2021
Trend
-10.1%
vs FY2020
Sector context
#48 of 205
Health Care
What the data says
Gilead Sciences's cash per share of $4.26 is higher than 77% of companies in the Health Care sector (FY2021). Cash per Share has fluctuated over the past 6 years, ranging from $4.26 in FY2021 to $9.81 in FY2017.
Based on SEC 10-K filings.
4.26 in FY2021 with a 5-year CAGR of -9.6%. Top quartile in the Health Care sector.
Declined from $9.07 to $4.26 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -9.8%
- 5-Year CAGR
- -9.6%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 205This company $4.26 Sector average $72.93
▼
-94.2% below sector average
Key checks
Key Insights
- In FY2021, cash per share decreased 10.1% year-over-year.
- Ranks #48 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2017.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $4.26 | -10.1% |
| FY2020 | $4.74 | -47.8% |
| FY2019 | $9.07 | +56.4% |
| FY2018 | $5.80 | -40.9% |
| FY2017 | $9.81 | +39.1% |
| FY2016 | $7.05 | -17.7% |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026